lymphoma
Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment
The test will identify patients expressing a genomic biomarker who are likely to respond to Denovo's investigational DB102 treatment for diffuse large B-cell lymphoma.
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2 mutation testing for patients with relapsed or refractory follicular lymphoma.
FDA Approves Epizyme's Tazverik, Roche CDx for EZH2-Mutated Follicular Lymphoma Patients
The accelerated approval is based on results from two cohorts of a Phase II, single-arm trial in which EZH2-mutated patients had an overall response rate of 69 percent.
Liquid Biopsy Effort Aims to Improve Diagnosis of Childhood Viral Lymphomas in Sub-Saharan Africa
Premium
A four-year, $5.5 million program will assess whether circulating cell-free DNA testing can improve diagnosis and outcomes for a type of EBV-associated cancer.
Veracyte Q4 Revenues Rise 15 Percent, Beat Wall Street Estimate
The firm posted $29.7 million in revenues, up about 15 percent from $25.8 million in Q4 2018 and slightly above the analysts' average estimate of $29.5 million.